Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
206 | 20344 | 32.2 | 72% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
352 | 31652 | MELANOMA//UVEAL MELANOMA//MALIGNANT MELANOMA |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MELANOMA | Author keyword | 1814 | 34% | 21% | 4332 |
2 | MALIGNANT MELANOMA | Author keyword | 533 | 42% | 5% | 983 |
3 | DERMOSCOPY | Author keyword | 404 | 61% | 2% | 431 |
4 | MELANOMA RESEARCH | Journal | 350 | 41% | 3% | 668 |
5 | SPITZ NEVUS | Author keyword | 242 | 86% | 1% | 123 |
6 | DERMATOSCOPY | Author keyword | 220 | 77% | 1% | 149 |
7 | CUTANEOUS MELANOMA | Author keyword | 220 | 64% | 1% | 214 |
8 | MELANOMA UNIT | Address | 181 | 73% | 1% | 140 |
9 | METASTATIC MELANOMA | Author keyword | 180 | 51% | 1% | 254 |
10 | MUCOSAL MELANOMA | Author keyword | 174 | 85% | 0% | 93 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MELANOMA | 1814 | 34% | 21% | 4332 | Search MELANOMA | Search MELANOMA |
2 | MALIGNANT MELANOMA | 533 | 42% | 5% | 983 | Search MALIGNANT+MELANOMA | Search MALIGNANT+MELANOMA |
3 | DERMOSCOPY | 404 | 61% | 2% | 431 | Search DERMOSCOPY | Search DERMOSCOPY |
4 | SPITZ NEVUS | 242 | 86% | 1% | 123 | Search SPITZ+NEVUS | Search SPITZ+NEVUS |
5 | DERMATOSCOPY | 220 | 77% | 1% | 149 | Search DERMATOSCOPY | Search DERMATOSCOPY |
6 | CUTANEOUS MELANOMA | 220 | 64% | 1% | 214 | Search CUTANEOUS+MELANOMA | Search CUTANEOUS+MELANOMA |
7 | METASTATIC MELANOMA | 180 | 51% | 1% | 254 | Search METASTATIC+MELANOMA | Search METASTATIC+MELANOMA |
8 | MUCOSAL MELANOMA | 174 | 85% | 0% | 93 | Search MUCOSAL+MELANOMA | Search MUCOSAL+MELANOMA |
9 | VEMURAFENIB | 168 | 65% | 1% | 159 | Search VEMURAFENIB | Search VEMURAFENIB |
10 | NEVUS | 160 | 56% | 1% | 194 | Search NEVUS | Search NEVUS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CUTANEOUS MELANOMA | 2259 | 59% | 12% | 2505 |
2 | MALIGNANT MELANOMA | 2122 | 36% | 23% | 4682 |
3 | CUTANEOUS MALIGNANT MELANOMA | 1233 | 61% | 6% | 1292 |
4 | MELANOCYTIC NEVI | 687 | 70% | 3% | 570 |
5 | EARLY STAGE MELANOMA | 559 | 69% | 2% | 480 |
6 | PIGMENTED SKIN LESIONS | 529 | 77% | 2% | 364 |
7 | AMERICAN JOINT COMMITTEE | 512 | 57% | 3% | 599 |
8 | PRIMARY CUTANEOUS MELANOMA | 509 | 74% | 2% | 375 |
9 | SUNSCREEN USE | 436 | 75% | 2% | 317 |
10 | METASTATIC MELANOMA | 425 | 25% | 7% | 1471 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MELANOMA RESEARCH | 350 | 41% | 3% | 668 |
2 | AMERICAN JOURNAL OF DERMATOPATHOLOGY | 59 | 13% | 2% | 435 |
3 | PIGMENT CELL & MELANOMA RESEARCH | 32 | 23% | 1% | 121 |
4 | SKIN RESEARCH AND TECHNOLOGY | 18 | 13% | 1% | 124 |
5 | JAMA DERMATOLOGY | 12 | 18% | 0% | 61 |
6 | CURRENT PROBLEMS IN DERMATOLOGY-US | 2 | 13% | 0% | 15 |
7 | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | 1 | 10% | 0% | 10 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Beyond BRAF: where next for melanoma therapy? | 2015 | 6 | 84 | 80% |
Emerging trends in the epidemiology of melanoma | 2014 | 23 | 6 | 100% |
International Prevalence of Indoor Tanning A Systematic Review and Meta-analysis | 2014 | 25 | 74 | 85% |
Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure | 2005 | 378 | 75 | 89% |
Medical progress - Management of cutaneous melanoma | 2004 | 419 | 88 | 83% |
Melanoma biology and new targeted therapy | 2007 | 530 | 90 | 42% |
Which drug, and when, for patients with BRAF-mutant melanoma? | 2013 | 67 | 53 | 72% |
Resistance to BRAF-targeted therapy in melanoma | 2013 | 64 | 57 | 72% |
Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond | 2014 | 32 | 138 | 55% |
Cutaneous melanoma | 2005 | 335 | 140 | 84% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MELANOMA UNIT | 181 | 73% | 0.7% | 140 |
2 | SYDNEY MELANOMA DIAGNOST | 127 | 92% | 0.2% | 49 |
3 | SYDNEY MELANOMA UNIT | 116 | 59% | 0.6% | 129 |
4 | VICTORIAN MELANOMA SERV | 76 | 88% | 0.2% | 36 |
5 | CUTANEOUS ONCOL | 72 | 53% | 0.5% | 96 |
6 | DERMATOL SKIN CANC UNIT | 63 | 76% | 0.2% | 44 |
7 | MELANOMA PROGRAM | 53 | 63% | 0.3% | 54 |
8 | MELANOMA | 50 | 47% | 0.4% | 80 |
9 | DERMATOEPIDEMIOL UNIT | 49 | 55% | 0.3% | 61 |
10 | MELANOMA AUSTRALIA | 45 | 59% | 0.3% | 51 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000010419 | BASAL CELL CARCINOMA//EXTRAMAMMARY PAGETS DISEASE//SEBACEOUS CARCINOMA |
2 | 0.0000009007 | VITILIGO//TYROSINASE//MELANOGENESIS |
3 | 0.0000008559 | UVEAL MELANOMA//CHOROIDAL MELANOMA//OCULAR ONCOL SERV |
4 | 0.0000004895 | SARCOPTES SCABIEI//SCABIES//HEAD LICE |
5 | 0.0000004834 | FIBRILLARY GLOMERULONEPHRITIS//NAIL PATELLA SYNDROME//YELLOW NAIL SYNDROME |
6 | 0.0000004738 | BRAIN METASTASES//WHOLE BRAIN RADIOTHERAPY//NEOPLASTIC MENINGITIS |
7 | 0.0000004552 | SUNSCREENS//UV FILTERS//PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE |
8 | 0.0000004516 | NUMB CHIN SYNDROME//CUTANEOUS METASTASES//ACROMETASTASIS |
9 | 0.0000004457 | SKIN RESEARCH AND TECHNOLOGY//STRATUM CORNEUM//TRANSEPIDERMAL WATER LOSS |
10 | 0.0000004298 | INTERNATIONAL JOURNAL OF HYPERTHERMIA//ISOLATED LIMB PERFUSION//LONIDAMINE |